Australian regulator pays Pan $55m after recall rethink
The Australian Therapeutic Goods Administration (TGA) will pay $55 million (€32.58m) to liquidated supplements manufacturer Pan Pharmaceuticals after inappropriately recalling the company’s entire 1600-product suite in 2003.